TEV-48125 for the preventive treatment of chronic migraine: Efficacy at early time points

OBJECTIVE: To evaluate the onset of efficacy of TEV-48125, a monoclonal antibody against calcitonin gene-related peptide, recently shown to be effective for the preventive treatment of chronic migraine (CM) and high-frequency episodic migraine. METHODS: A randomized placebo-controlled study tested o...

詳細記述

保存先:
書誌詳細
出版年:Neurology
主要な著者: Bigal, Marcelo E., Dodick, David W., Krymchantowski, Abouch V., VanderPluym, Juliana H., Tepper, Stewart J., Aycardi, Ernesto, Loupe, Pippa S., Ma, Yuju, Goadsby, Peter J.
フォーマット: Artigo
言語:Inglês
出版事項: Lippincott Williams & Wilkins 2016
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4932236/
https://ncbi.nlm.nih.gov/pubmed/27281531
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000002801
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料